SG153848A1 - Aequorin-containing compositions and methods of using same - Google Patents
Aequorin-containing compositions and methods of using sameInfo
- Publication number
- SG153848A1 SG153848A1 SG200904273-0A SG2009042730A SG153848A1 SG 153848 A1 SG153848 A1 SG 153848A1 SG 2009042730 A SG2009042730 A SG 2009042730A SG 153848 A1 SG153848 A1 SG 153848A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- aequorin
- same
- containing compositions
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/872,795 US20060229243A1 (en) | 2004-06-21 | 2004-06-21 | Aequorin-containing compositions and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
SG153848A1 true SG153848A1 (en) | 2009-07-29 |
Family
ID=35785748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200904273-0A SG153848A1 (en) | 2004-06-21 | 2005-06-21 | Aequorin-containing compositions and methods of using same |
Country Status (21)
Country | Link |
---|---|
US (3) | US20060229243A1 (zh) |
EP (2) | EP1768691B1 (zh) |
JP (1) | JP4971150B2 (zh) |
KR (1) | KR101213555B1 (zh) |
CN (1) | CN1997383B (zh) |
AU (1) | AU2005265266B2 (zh) |
BR (1) | BRPI0512392B1 (zh) |
CA (1) | CA2571542C (zh) |
CY (1) | CY1114307T1 (zh) |
DK (1) | DK1768691T3 (zh) |
ES (1) | ES2422173T3 (zh) |
HK (1) | HK1109576A1 (zh) |
IL (1) | IL180195A (zh) |
MX (1) | MXPA06015037A (zh) |
NZ (1) | NZ552274A (zh) |
PL (1) | PL1768691T3 (zh) |
PT (1) | PT1768691E (zh) |
SG (1) | SG153848A1 (zh) |
SI (1) | SI1768691T1 (zh) |
WO (1) | WO2006010004A2 (zh) |
ZA (1) | ZA200610688B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
GB0625678D0 (en) | 2006-12-21 | 2007-01-31 | Lux Biotechnology Ltd | Composition and method for detection of demineralisation |
CA2717322C (en) | 2008-03-11 | 2017-07-11 | Quincy Bioscience, Llc | Apoaequorin-containing compositions and methods of using same |
JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
EP2657336B1 (en) * | 2010-12-24 | 2018-07-04 | Otsuka Pharmaceutical Co., Ltd. | Bioassay method for detecting physiologically active substance |
CA2855719C (en) * | 2011-11-15 | 2021-10-26 | Quincy Bioscience, Llc | Apoaequorin for reducing neuronal injury due to ischemia |
GB201700317D0 (en) | 2017-01-09 | 2017-02-22 | Calcivis Ltd | Detection device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240855A (ja) * | 2000-03-01 | 2001-09-04 | Masashi Sugimoto | 生物発光方法及び発光物品 |
US6800492B2 (en) * | 2000-06-01 | 2004-10-05 | Institute Pasteur | Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
US6930169B2 (en) * | 2000-06-12 | 2005-08-16 | University Of Baltimore Biotechnology Institute | Method of controlling the binding of calmyrin to presenilin |
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
-
2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
-
2005
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/en active Active
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/en not_active Not-in-force
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko active IP Right Grant
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh active Active
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en unknown
- 2005-06-21 CA CA2571542A patent/CA2571542C/en active Active
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja active Active
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es active Active
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt active IP Right Grant
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en active Active
- 2005-06-21 US US11/571,043 patent/US7671015B2/en active Active
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/en active Application Filing
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
-
2006
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
-
2008
- 2008-01-10 HK HK08100338.3A patent/HK1109576A1/xx unknown
-
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
-
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100051I1 (hu) | Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére | |
SG153848A1 (en) | Aequorin-containing compositions and methods of using same | |
GB0515353D0 (en) | Food | |
IL187382A0 (en) | Bicyclic derivatives as modulators of ion channels | |
GEP20084550B (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
MXPA06014510A (es) | Composiciones y metodos para tratar trastornos inflamatorios. | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
TW200740803A (en) | Heterocyclic derivatives as modulators of ion channels | |
EP1999626A4 (en) | METHODS, COMPOSITIONS AND NEEDS FOR TREATING MUSCULOSKELETAL DISORDERS AND SYMPTOMS ASSOCIATED THEREWITH | |
TW200604168A (en) | Azaindoles useful as inhibitors of rock and other protein kinases | |
MX2010003864A (es) | Amidas utiles como inhibidores de canales de sodio dependientes de voltaje. | |
TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
TW200611702A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
TW200724140A (en) | Hydantoin compounds | |
TW200602052A (en) | Azaindoles useful as inhibitors of JAK and other protein kinases | |
MY157365A (en) | Chemical compounds and uses | |
TW200714277A (en) | Methods and compositions for altering cell fuction | |
MX2010003865A (es) | Aril amidas utiles como inhibidores de canales de sodio dependientes de voltaje. | |
HK1104544A1 (en) | Quinazolines useful as modulators of ion channels | |
UA91848C2 (ru) | Применение соединений диосметина в лечении и предотвращении тромботическим патологиям | |
EA201070423A1 (ru) | Диарильные соединения оксадиазолов | |
MX2010003009A (es) | Piridil sulfonamidas como moduladores de canales ionicos. | |
TW200700064A (en) | Novel compounds | |
NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
GEP20115201B (en) | Cinnamoyl-piperazine derivatives and their use as par- i antagonists |